Allspring Global Investments
PNT

Allspring Global Investments’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Allspring Global Investments’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-77,736
Closed -$518K – 2838
2023
Q3 		$518K Sell
77,736
-38,317
-33% -$318K ﹤0.01% 1518
2023
Q2 		$1.05M Buy
116,053
+60,165
+108% +$531K ﹤0.01% 1399
2023
Q1 		$406K Sell
55,888
-5,415
-9% -$40.2K ﹤0.01% 1632
2022
Q4 		$447K Sell
61,303
-220
-0.4% -$1.63K ﹤0.01% 1622
2022
Q3 		$475K Buy
+61,523
New +$522K ﹤0.01% 1596

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Allspring Global Investments's PNT Position: Q4 2023 in Review

Allspring Global Investments sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 77,736 shares — an estimated $518K sold.

Allspring Global Investments first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $1.05M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Allspring Global Investments reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 77,736 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $518K.
  • Allspring Global Investments first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Allspring Global Investments's POINT Biopharma Global Inc. Common Stock position peaked at $1.05M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.